Comparison the effect of Single Dose versus Divided Dose of ASA on endothelial function in diabetic patients (Type2): A Randomized Clinical Trial
Phase 3
Recruiting
- Conditions
- ewly diagnosed Diabetes mellitus without complication.Type 2 diabetes mellitus without complicationsE11.9
- Registration Number
- IRCT20191101045301N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Age more than 40 year
Diabetes Melitus
ASCVD Score more than 7.5
Exclusion Criteria
Any cardiovascular disease
Any cerebrovascular disease
Any cardiac arrhythmia
Any anti platelet or anticoagulant consumption
Suffering from acute or chronic infection
Platelet disturbance or bleeding tendency
NSAIDs consumption in recent 14 days
Platelet count less than 120000
Smoking
Chronic Kidney Disease (CKD)
GI Bleeding
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Flow Mediated Dilation. Timepoint: Bse line, 1 hour after treatment,6 days after treatment( one hour before last dose), 6 days after treatment( one hour after last dose). Method of measurement: Echocardiography.
- Secondary Outcome Measures
Name Time Method